Vaccine News and Research

Latest Vaccine News and Research

Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer

A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

24 Jul 2017

High dose flu vaccine reduces risk of respiratory and all-cause hospitalizations, study finds

In the largest nursing home study to date on the effect of a high dose (HD) flu vaccine, researchers found that vaccines with four times the antigen of standard flu (SD) vaccines significantly reduced the risk of respiratory and all-cause hospitalization during flu season.

21 Jul 2017

Cow immunization may lead to new human vaccines and treatments for HIV, study finds

Antibodies against the Human Immunodeficiency Virus (HIV) have been obtained for the first time by injecting cows with an HIV antigen. This achievement offers promise for the development of anti-HIV treatments or vaccines.

21 Jul 2017

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

Kent State professor offers reliable information about vaccine safety, urges to promote immunization

The center of a public health debate is whether parents should have their children vaccinated. Tara Smith, Ph.D., professor of epidemiology at Kent State University's College of Public Health, challenges statements made by influential individuals who oppose the widespread use of vaccines, and she calls upon her colleagues in the scientific community to speak out to promote vaccination.

19 Jul 2017

Parents may be less sure about vaccine needs for teens, new poll suggests

Parents may be up to speed on what vaccines their children need for kindergarten, but may be less sure during high school years, a new national poll suggests.

17 Jul 2017

Prior dengue fever in people infected by Zika does not lead to worse illness

Individuals who are infected by Zika virus after having dengue fever do not appear to become more severely ill than people with Zika who have never had dengue.

14 Jul 2017

Zika virus affecting teenage mothers in Brazil

Zika virus transmitted by mosquitoes is affecting scores of teenage girls in the latest Brazilian Zika outbreak. The consequences of this could be serious say experts

14 Jul 2017

Potential vaccines could protect developing fetus from Zika virus, UTMB study shows

Immunizing female mice with a Zika vaccine can protect their developing fetus from infection and birth defects during pregnancy, according to new research from The University of Texas Medical Branch at Galveston.

13 Jul 2017

Measles outbreak - 35 reported deaths in Europe

Over the last 12 month, there have been 35 reported deaths due to the ongoing measles outbreak in the WHO European Region says a new report.

12 Jul 2017

World Health Organization not sending cholera vaccines to Yemen

The World Health Organization (WHO) said on Tuesday that there was no chance the agency would attempt to vaccinate Yemen against cholera due to the fact that the disease has spread so widely there that such an effort would be fruitless. This is a U-turn on a decision made by the organization a month ago. On June 15th this year, the WHO had decided to send one million doses of cholera vaccine to Yemen in collaboration with some other partners. This was following a request from Yemen’s internationally recognized government. This new decision revokes the earlier plans.

12 Jul 2017

New DNA-based vaccine protects testes, sperm from Zika-related damage in mouse models

While the Zika virus is primarily transmitted by mosquitoes, research has shown that the disease can affect semen and sperm and can therefore be spread through sexual intercourse.

11 Jul 2017

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.

11 Jul 2017

First vaccine protecting against gonorrhea provides opportunity for vaccine development

A meningococcal group B vaccine has been found to offer protection against gonorrhea, report researchers. This is the first time a vaccine has protected against the STD and it could open up a new pathway for vaccine development.

11 Jul 2017

Research highlights need for vaccines to prevent child deaths from fatal lung infections

Vaccines to combat a virus that can lead to fatal lung infections are urgently needed to help prevent child deaths worldwide, research suggests.

10 Jul 2017

Rise in antibiotic-resistant gonorrhea, WHO report reveals

Reports from WHO, based on the data collected from 77 countries, reveals that antibiotic resistance of gonorrhea, a common sexually transmitted infection is making the disease much harder and at times impossible to treat.

7 Jul 2017

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments.

6 Jul 2017

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.

6 Jul 2017

Zika: costs of prevention and control

They undertook a modelling study based on six states in the US in areas that are at risk of Zika emergence. The main finding of this study was that the total cost of Zika in these sates had a range that went from approximately 183.4 million dollars to 1.2 billion dollars.

6 Jul 2017

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

5 Jul 2017

Vaccine News and Research

Latest Vaccine News and Research

Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer

High dose flu vaccine reduces risk of respiratory and all-cause hospitalizations, study finds

Cow immunization may lead to new human vaccines and treatments for HIV, study finds

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

Kent State professor offers reliable information about vaccine safety, urges to promote immunization

Parents may be less sure about vaccine needs for teens, new poll suggests

Prior dengue fever in people infected by Zika does not lead to worse illness

Zika virus affecting teenage mothers in Brazil

Potential vaccines could protect developing fetus from Zika virus, UTMB study shows

Measles outbreak - 35 reported deaths in Europe

World Health Organization not sending cholera vaccines to Yemen

New DNA-based vaccine protects testes, sperm from Zika-related damage in mouse models

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

First vaccine protecting against gonorrhea provides opportunity for vaccine development

Research highlights need for vaccines to prevent child deaths from fatal lung infections

Rise in antibiotic-resistant gonorrhea, WHO report reveals

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

Zika: costs of prevention and control

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in